The group of Sara Wickström is looking for Post-doctoral Researchers in Stem Cell Research at University of Helsinki27.5.2018
Helsinki Institute of Life Science, HiLIFE, is a new life science institute at the University of Helsinki, a leading Nordic university with a strong life science research. HiLIFE operates mainly in the campuses of Meilahti and Viikki. In Meilahti, top-notch medical research, education and care meet daily to benefit of the patients and the entire society. Meilahti provides access to state of the art core facilities for imaging, genomics, proteomics and metabolomics, as well as bioinformatics. It is also home to the Faculty of Medicine and the Helsinki University Central Hospital (HUCH) which makes it an interactive research community with interests in a broad range of topics from fundamental biology to clinical applications.
The group of Sara Wickström is looking for ERC-Funded Post-doctoral Researchers in Stem Cell Research for 2 years fixed term (with 6 month trial period) starting from 1.8.2018 with possibility of extension up to 4 years.
The successful candidate will join a young and dynamic research team in the analysis of stem cell regulation in tissue morphogenesis, maintenance and cancer. We employ a wide range of techniques, including mouse genetics, cell biology, live cell imaging, mass spectrometry and single cell sequencing to study how stem cell and cancer stem cell fate is regulated through interactions with their niche.
The applicant is required to hold PhD in biology, genetics, bioengineering, biochemistry, or a related field, as well as strong written and oral communication skills. The working language is of the lab is English; knowledge of the Finnish language is not necessary. Experience in cell biology is required, experience in computational data analysis and next generation sequencing is an advantage.
More information and application at https://www.helsinki.fi/fi/avoimet-tyopaikat/post-doctoral-researchers-in-stem-cell-research
Deadline for applications is June 30, 2018.